# A Study Comparing the Efficacy of TA103 and the Placebo Control in the Treatment of Interdigital Tinea Pedis.

> **NCT04883593** · EARLY_PHASE1 · COMPLETED · sponsor: **Sun Pharmaceutical Industries, Inc.** · enrollment: 160 (actual)

## Conditions studied

- Tinea Pedis

## Interventions

- **DRUG:** TA103
- **DRUG:** Placebo Control

## Key facts

- **NCT ID:** NCT04883593
- **Lead sponsor:** Sun Pharmaceutical Industries, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-09-03
- **Primary completion:** 2021-02-20
- **Final completion:** 2021-02-20
- **Target enrollment:** 160 (ACTUAL)
- **Last updated:** 2021-05-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04883593

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04883593, "A Study Comparing the Efficacy of TA103 and the Placebo Control in the Treatment of Interdigital Tinea Pedis.". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04883593. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*